跳至主要内容
临床试验/NCT03405402
NCT03405402已完成不适用

Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization

Hanane EL KENZ3 个研究点 分布在 1 个国家目标入组 173 人开始时间: 2018年2月13日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
173
试验地点
3
主要终点
Irregular antibodies

研究概览

简要总结

Sickle cell patients have a high prevalence of alloimmunization. This high rate of alloimmunization can be partially explained by the existence of an antigenic difference between the predominantly Caucasian donor population and the sickle cell patients of African origin. Genetic and environmental risk factors have also been described.

The main risk factors that have been shown in retrospective or cross-sectional studies are some HLA alleles, the age of the patient, the number of leukocyte-depleted erythrocyte concentrates (CED) transfused, the number of transfusion episodes, the age of the CEDs, the existence of an inflammatory event at the time of transfusion and the presence of anti-erythrocyte autoantibodies.There is also evidence of an impaired TH response but the underlying immunological mechanism is not fully understood.

The aim of this study is to study the prevalence and the risk factors for anti-erythrocyte alloimmunization and to try to understand the immunological mechanisms.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Sickle cell disease patients treated within the CHU Brugmann or Queen Fabiola Children's Hospital

排除标准

  • 未提供

研究组 & 干预措施

Control group

Other

Allo-immunization not detected

干预措施: Blood sampling (Procedure)

Experimental group

Experimental

Allo-immunization detected (positive response for irregular antibodies 2 to 4 weeks after a blood transfusion)

干预措施: Blood sampling (Procedure)

结局指标

主要结局

Irregular antibodies

时间窗: Between 2 to 4 weeks after blood transfusion

Presence/abscence of irregular antibodies

C-reactive protein (CRP)

时间窗: 1 hour before blood transfusion

CRP dosage

Heme oxygenase

时间窗: Between 2 to 4 weeks after blood transfusion

Heme oxygenase dosage

Cytokine

时间窗: Between 2 to 4 weeks after blood transfusion

Cytokine dosage

Lymphocyte typing

时间窗: Between 2 to 4 weeks after blood transfusion

Lymphocyte typing

次要结局

  • Chronic or acute blood transfusion(1 hour before blood transfusion)
  • Sex(1 hour before blood transfusion)
  • Blood donor ethnicity(1 hour before blood transfusion)
  • Blood transfusion indication(1 hour before blood transfusion)

研究者

发起方
Hanane EL KENZ
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hanane EL KENZ

Head of Blood Bank

Brugmann University Hospital

研究点 (3)

Loading locations...

相似试验